The Efficacy of Burosumab Treatment for Hypophosphatemic Rickets: Systematic Review
Ibrahim Alnajashi, Wejdan Alshehri & Noor Shihabi · Asian Journal of Medicine and Health · 2023
Background/Objective: The approval of burosumab for the treatment of X-linked hypophosphatemia (XLH) in adults and children is a significant milestone. Nevertheless, there is a scarcity of data regarding its safety and efficacy in adolescents. The primary objective of this resear...
Open access
Research Article
10.9734/ajmah/2023/v21i12965